IONS
#906
Ionis Pharmaceuticals, Inc. - Common Stock
62.4 3 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.47%
Monthly Change
+13.32%
6 month change
-21.44%
Year Change
-13.44%
Previous Close
63.3 6
Open
62.4 3
Low
62.4 3
High
62.4 3
Volume
151
Financials
- Market Capitalization 10.37 B
- Employee 1 402
- Founded 1989
- CEO Brett P. Monia Ph.D.
- Website www.ionis.com
- Headquarter California, United States
- FIGI BBG000JH6683
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-68.35
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 880 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 206.27 USD | -0.42% | -0.46% | -12.56% | +58.43% | 10.80 B USD | ||
| 896 |  KRYS Krystal Biotech, Inc. - Common Stock | 357.46 USD | -0.64% | +5.93% | -1.23% | +91.02% | 10.58 B USD | ||
| 911 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 367.85 USD | -2.52% | +0.23% | +22.21% | +699.33% | 10.27 B USD | ||
| 917 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.80 USD | +1.42% | +1.72% | -2.06% | +101.29% | 10.15 B USD |
Frequently asked questions about Ionis Pharmaceuticals, Inc. Common Stock
What is the Ionis Pharmaceuticals, Inc. Common Stock stock price today?
The current price of Ionis Pharmaceuticals, Inc. Common Stock (IONS) is 62.43. Over the past 24 hours, the stock has changed by -1.47%. Follow the IONS chart for real-time price dynamics.
What is the stock ticker of Ionis Pharmaceuticals, Inc. Common Stock?
Ionis Pharmaceuticals, Inc. Common Stock trades under the ticker IONS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ionis Pharmaceuticals, Inc. Common Stock stock going up?
IONS has changed by +4.68% over the last week, +13.32% over the last month, and -13.44% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Ionis Pharmaceuticals, Inc. Common Stock?
Ionis Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 10.37 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Ionis Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, Ionis Pharmaceuticals, Inc. Common Stock reported earnings of -0.69 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Ionis Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
Ionis Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 267.95 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Ionis Pharmaceuticals, Inc. Common Stock net income for the last quarter?
Ionis Pharmaceuticals, Inc. Common Stock reported net income of -114.65 M for the last quarter. The previous quarter showed -92.53 M, which means net income changed by -23.90%.
How many employees does Ionis Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, Ionis Pharmaceuticals, Inc. Common Stock has 1 402 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ionis Pharmaceuticals, Inc. Common Stock EBITDA?
Ionis Pharmaceuticals, Inc. Common Stock EBITDA is -99.04 M, and its EBITDA margin is -36.96%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ionis Pharmaceuticals, Inc. Common Stock stock?
You can buy Ionis Pharmaceuticals, Inc. Common Stock (IONS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ionis Pharmaceuticals, Inc. Common Stock stock?
Investing in Ionis Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IONS chart and related analysis on metatrader.com as part of your research.